drugset / Trial / NCT01897116
A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
NaSingle-groupSingle-blindTreatment
Summary
This is a Phase I study combining vemurafenib and hydroxychloroquine in the treatment of BRAF V600E+ metastatic melanoma.
Timeline
- Start
- 2013-06
- Primary completion
- 2016-07-12
- Completion
- 2016-10-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | — | — |
| Subject | Vemurafenib | Small molecule | — | — |